Items where Author is "Hanley, NA"
 | Up a level |
Group by: Item Type | No Grouping
Jump to: Article
Number of items: 4.
Article
Athwal, VS, Pritchett, James, Llewellyn, J, Martin, K, Camacho, E, Raza, SMA, Phythian‐Adams, A, Birchall, LJ, Mullan, AF, Su, K, Pearmain, L, Dolman, G, Zaitoun, AM, Friedman, SL, MacDonald, A, Irving, WL, Guha, IN, Hanley, NA and Piper Hanley, K
(2017)
SOX9 predicts progression toward cirrhosis in patients while its loss protects against liver fibrosis.
EMBO Molecular Medicine, 9 (12).
pp. 1696-1710.
ISSN 1757-4676
Martin, K, Pritchett, J, Llewellyn, J, Mullan, AF, Athwal, VS, Dobie, R, Harvey, E, Zeef, L, Farrow, S, Streuli, C, Henderson, NC, Friedman, SL, Hanley, NA and Piper Hanley, K
(2016)
PAK proteins and YAP-1 signalling downstream of integrin beta-1 in myofibroblasts promote liver fibrosis.
Nature Communications, 7.
ISSN 2041-1723
Pritchett, J, Athwal, VS, Harvey, E, Martin, K, Llewellyn, J, Ireland, P, Nicolaides, A, Humphries, MJ, Bobola, N, Hanley, NA and Piper Hanley, K
(2014)
Epimorphin alters the inhibitory effects of SOX9 on Mmp13 in activated hepatic stellate cells.
PloS one, 9 (6).
ISSN 1932-6203
Pritchett, J, Harvey, E, Athwal, V, Berry, A, Rowe, C, Oakley, F, Moles, A, Mann, DA, Bobola, N, Sharrocks, AD, Thomson, BJ, Zaitoun, AM, Irving, WL, Guha, IN, Hanley, NA and Hanley, KP
(2012)
Osteopontin is a novel downstream target of SOX9 with diagnostic implications for progression of liver fibrosis in humans.
Hepatology, 56 (3).
pp. 1108-1116.
ISSN 0270-9139